Saturday, 13 September, 2025г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

Daniel Catenacci, MD, elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 2020

Daniel Catenacci, MD, elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 2020У вашего броузера проблема в совместимости с HTML5
Dr. Catenacci, Associate Professor, The University of Chicago Medical Center and Biological Sciences, elaborates on the need for quick responses and immunotherapy in gastroesophageal cancer patients discussed in the Javelin 100 study being presented at ASCO GI 2020
Опубликовано: 25-01-2020
Теги: ASCO GI ASCO GI 2020 obr obroncology JAVELIN 100 gastroesophageal cancer treatment

Похожие видео
David H Ilson, MD, elaborates on updated data from the BEACON study presented at ASCO GI 2020

David H Ilson, MD, elaborates on updated data from the BEACON study presented at ASCO GI 202002:23

Daniel Petrylak, MD shares his thoughts on the CARD study presented at ASCO GU 2020

Daniel Petrylak, MD shares his thoughts on the CARD study presented at ASCO GU 202000:56

Pembrolizumab shows promising activity against head and neck cancer

Pembrolizumab shows promising activity against head and neck cancer07:38

Tomorrow’s Breakthroughs Today: Immunotherapy and the Cancer Research Institute

Tomorrow’s Breakthroughs Today: Immunotherapy and the Cancer Research Institute02:58

Мой аккаунт

Вход / Log In